CompletedNot Applicable

Evaluating Cancer Survivorship Care Models

United States991 participantsStarted 2013-07

Plain-language summary

The Evaluating Cancer Survivorship Care Models project is an innovative 3-year study that is collecting data to help understand how to best deliver follow-up care to cancer survivors. Cancer is a complex disease requiring complex treatments that can cause lasting impacts after treatment ends. Some patients face physical, psychosocial, spiritual and/or practical challenges as they adjust to life after cancer. Fortunately, health care providers have begun to focus on the consequences of cancer and its treatment and are more actively working with cancer survivors to manage post-treatment needs and care. Led by the George Washington University and funded by the Patient-Centered Outcomes Research Institute, this project brings together representatives from the Commission on Cancer, the Cancer Support Community, LIVESTRONG and the American Cancer Society as well as cancer survivors and healthcare professionals to better understand how different strategies or models of care impact outcomes that are most important to cancer survivors. The project will focus on survivors of breast, prostate and colorectal cancers and will be relevant for understanding the needs and preferences of survivors of other cancers as well. The emphasis is on patient-centered outcomes, which are outcomes that are most significant to patients, such as patient satisfaction and quality of life.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * English-speaking survivors of non-metastatic breast, prostate or colorectal cancers * Completed active treatment (chemotherapy, radiation, and/or surgery), but may be on hormonal medication, aromatase inhibitors or other maintenance therapy * Diagnosed at 18 years old or older * First survivorship care appointment has been scheduled but not completed * Be a patient at one of the high-performing cancer programs selected to participate in the CER study Exclusion criteria * Diagnosed with cancer other than breast, prostate or colorectal cancer * Not English-speaking * Currently undergoing active treatment (defined as chemotherapy, radiation, and/or surgery) * Cancer has metastasized * Diagnosed at under 18 years old * Have completed first appointment with the survivorship program * Not a patient at one of the high-performing cancer programs selected to participate in the CER study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Percentage of Survivors Reporting "Yes Definitely" Across Items Within Each of 9 Factors Reflecting Survivorship Care Quality

Timeframe: Patients complete a survey within one week after their survivorship visit, and 6 months post visit.

Average Number of Quality of Life Top Concerns Reported Converted to a Percentage

Timeframe: Patients complete a survey at baseline before their survivorship visit, and 6 months post visit.

Self- Efficacy Score

Timeframe: Patients complete a survey at baseline before their survivorship visit, within one week after their survivorship visit, 3 months post visit, and 6 months post visit.

Frequency of Visit

Timeframe: Patients complete a survey at baseline before their survivorship visit, 3 months post visit, and 6 months post visit.

Trial details

NCT IDNCT02362750

SponsorGeorge Washington University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-10

Results submitted2018-03-19

View on ClinicalTrials.gov More Quality of Life trials